Low-Dose Semaglutide Attenuates Cardiac Lipid Content and Hepatic Steatosis in Cardiometabolic HFpEF: Weight Loss Independent Actions of GLP-1 Receptor Activation

AHA Scientific Sessions 2025 Abstract

The paper

Elbatreek M, Li Z, Shah S et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4359454

doi.org/10.1161/circ.152.suppl_3.4359454